Weekly Investment Analysts’ Ratings Changes for Sartorius (SRT3)

A number of firms have modified their ratings and price targets on shares of Sartorius (FRA: SRT3) recently:

  • 2/7/2018 – Sartorius was given a new €86.00 ($106.17) price target on by analysts at HSBC Holdings plc. They now have a “neutral” rating on the stock.
  • 2/2/2018 – Sartorius was given a new €75.00 ($92.59) price target on by analysts at Nord/LB. They now have a “sell” rating on the stock.
  • 2/1/2018 – Sartorius was given a new €90.00 ($111.11) price target on by analysts at Deutsche Bank AG. They now have a “neutral” rating on the stock.
  • 1/31/2018 – Sartorius was given a new €90.00 ($111.11) price target on by analysts at Warburg Research. They now have a “buy” rating on the stock.
  • 1/31/2018 – Sartorius was given a new €85.00 ($104.94) price target on by analysts at Berenberg Bank. They now have a “buy” rating on the stock.
  • 1/31/2018 – Sartorius was given a new €78.00 ($96.30) price target on by analysts at Kepler Capital Markets. They now have a “neutral” rating on the stock.
  • 1/22/2018 – Sartorius was given a new €80.00 ($98.77) price target on by analysts at Deutsche Bank AG. They now have a “neutral” rating on the stock.
  • 1/10/2018 – Sartorius was given a new €60.00 ($74.07) price target on by analysts at Hauck & Aufhaeuser. They now have a “sell” rating on the stock.
  • 1/10/2018 – Sartorius was given a new €76.00 ($93.83) price target on by analysts at Commerzbank Ag. They now have a “neutral” rating on the stock.
  • 1/4/2018 – Sartorius was given a new €78.00 ($96.30) price target on by analysts at Kepler Capital Markets. They now have a “neutral” rating on the stock.

Sartorius AG (FRA:SRT3) opened at €98.45 ($121.54) on Monday. The company has a market cap of $6,890.00 and a price-to-earnings ratio of 80.04. Sartorius AG has a 52-week low of €65.30 ($80.62) and a 52-week high of €100.00 ($123.46).

Sartorius Aktiengesellschaft provides laboratory and process technologies and equipment worldwide. The company operates through two divisions, Bioprocess Solutions, and Lab Products & Services. The Bioprocess Solutions division offers products, technologies, and services ranging from fermentation, cell cultivation, filtration, and purification to media storage and transportation for the biopharmaceutical industry.

Receive News & Ratings for Sartorius AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sartorius AG and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply